Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Taylor

Showing results (661-670 of 1,000) with videos related to

Pageof 100
Sort By:
BMC Public Health|June 6, 2022
Mediators of socioeconomic inequalities in preterm birth: a systematic reviewPhilip McHale, Gillian Maudsley, Andy Pennington, et al.
Journal of Psychopharmacology (Oxford, England)|February 13, 2021
Point-of-care measurement of clozapine concentration using a finger-stick blood sampleDavid Taylor, Matthew Atkins, Robert Harland, et al.
Journal of Autism and Developmental Disorders|February 21, 2014
Screening, intervention and outcome in autism and other developmental disorders: the role of randomized controlled trialsElisabeth Fernell, Philip Wilson, Nouchine Hadjikhani, et al.
Schizophrenia Bulletin|October 5, 2023
Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic RelapseRobert A McCutcheon, David Taylor, Jose Rubio, et al.
The Medical Journal of Australia|August 27, 2019
Pilot trial of digital breast tomosynthesis (3D mammography) for population-based screening in BreastScreen VictoriaNehmat Houssami, Darren Lockie, Michelle Clemson, et al.
BMJ (Clinical Research Ed.)|February 25, 2016
Investment in Sure Start children's centres is needed more than everMelisa C Campbell, Melissa Gladstone, Clare Oliver, et al.
Thorax|March 26, 2013
Author’s response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal studyDavid Taylor-Robinson, Margaret Whitehead, Finn Diderichsen, et al.
Journal of the American Medical Directors Association|September 2, 2021
Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with Worse Outcomes in DementiaDelia Bishara, Gayan Perera, Daniel Harwood, et al.
Bjpsych Bulletin|July 9, 2019
Safe prescribing in cognitively vulnerable patients: the use of the anticholinergic effect on cognition (AEC) tool in older adult mental health servicesDelia Bishara, Charlotte Scott, Robert Stewart, et al.
Journal of Epidemiology and Community Health|September 23, 2018
How well can poor child health and development be predicted by data collected in early childhood?Viviane S Straatmann, Anna Pearce, Steven Hope, et al.
Pageof 100

Showing results (661-670 of 1,000) with videos related to

Sort By:
Pageof 100
BMC Public Health|June 6, 2022
Mediators of socioeconomic inequalities in preterm birth: a systematic reviewPhilip McHale, Gillian Maudsley, Andy Pennington, et al.
Journal of Psychopharmacology (Oxford, England)|February 13, 2021
Point-of-care measurement of clozapine concentration using a finger-stick blood sampleDavid Taylor, Matthew Atkins, Robert Harland, et al.
Journal of Autism and Developmental Disorders|February 21, 2014
Screening, intervention and outcome in autism and other developmental disorders: the role of randomized controlled trialsElisabeth Fernell, Philip Wilson, Nouchine Hadjikhani, et al.
Schizophrenia Bulletin|October 5, 2023
Does Slow and Steady Win the Race? Rates of Antipsychotic Discontinuation, Antipsychotic Dose, and Risk of Psychotic RelapseRobert A McCutcheon, David Taylor, Jose Rubio, et al.
The Medical Journal of Australia|August 27, 2019
Pilot trial of digital breast tomosynthesis (3D mammography) for population-based screening in BreastScreen VictoriaNehmat Houssami, Darren Lockie, Michelle Clemson, et al.
BMJ (Clinical Research Ed.)|February 25, 2016
Investment in Sure Start children's centres is needed more than everMelisa C Campbell, Melissa Gladstone, Clare Oliver, et al.
Thorax|March 26, 2013
Author’s response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal studyDavid Taylor-Robinson, Margaret Whitehead, Finn Diderichsen, et al.
Journal of the American Medical Directors Association|September 2, 2021
Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with Worse Outcomes in DementiaDelia Bishara, Gayan Perera, Daniel Harwood, et al.
Bjpsych Bulletin|July 9, 2019
Safe prescribing in cognitively vulnerable patients: the use of the anticholinergic effect on cognition (AEC) tool in older adult mental health servicesDelia Bishara, Charlotte Scott, Robert Stewart, et al.
Journal of Epidemiology and Community Health|September 23, 2018
How well can poor child health and development be predicted by data collected in early childhood?Viviane S Straatmann, Anna Pearce, Steven Hope, et al.
Pageof 100